CDKN2A and neoplasm: Zhou et al studied tumor-associated antigens P53, IMP1, P16, cyclin B1, P62, and C-myc for screening high-risk subjects and early detection of ESCC.[41] The autoantibody assay successively accumulated 6 antigens.